Introduction
It is estimated that 8 % of the human genome comprises endogenous retroviruses (HERVs) (Lander et al., 2001) , which can be classified into at least 31 distinct families (Bannert & Kurth, 2006; Katzourakis & Tristem, 2005) . Of these, the HERV-K (HML-2) family shows evidence of recent activity within the human genome (Marchi et al., 2014) . Amplification of endogenous retroviruses (ERVs) within mammalian genomes occurred either by extracellular reinfection of germline cells (Dewannieux et al., 2006) or by retrotransposition, with the latter producing the largest ERV families (Magiorkinis et al., 2012) . No single HERV locus has been found that can produce infectious virions (Kassiotis, 2014) , but the reconstitution of an ancestral HERV-K (HML-2) genome resulted in the production of functional infectious viral particles (Dewannieux et al., 2006; Lee & Bieniasz, 2007) . Here, we review the biological role of HERV expression and how it could result in innate immune activation. We will first provide an outline of the mechanisms of innate immunity and then discuss how these may be used to detect and limit HERV expression.
Expression and biological roles of HERVs
The existence of endogenous retroviruses in mammalian genomes has been known since the 1970s (Coffin, 1979) . Early studies showed the presence of retrovirus-like particles in placentae of humans and non-human primates (Kalter et al., 1973) . Further studies identified virus-like particles in cancers including human teratocarcinomas (Harzmann et al., 1982) and cloned full-length sequences of several HERVs (Bonner et al., 1982; Repaske et al., 1985) . Subsequently, the multicopy nature of these elements was described, with HERV-K initially thought to be present at 30-50 copies per haploid genome (Ono, 1986) . HERV mRNA was detected in normal and malignant human tissues (Cohen et al., 1988; Kato et al., 1987; Medstrand et al., 1992) , with variation among tissues in the length, quantity and content of the HERVs (Rabson et al., 1983) . More recently, a survey was made of the genome for complete proviral elements and to quantify the transcription of these elements in healthy human tissues (de Parseval et al., 2003) . Of the more than 10 000 retroviral elements, there were 476 potential complete env genes and, of these, 16 were found to encode potentially full-length envelope proteins (de Parseval et al., 2003) . Ultimately, these full-length env genes were used to design primers for quantitative reverse transcription-PCR, which showed variation in tissue-specific expression of the HERV env genes (de Parseval et al., 2003) . Importantly, it also showed that the promoters are active, allowing transcription of these genes (de Parseval et al., 2003) .
The expression of HERVs is thought to be analogous to the replication of exogenous retroviruses, with transcription of the provirus followed by export of the mRNA and translation of viral proteins. Furthermore, the RNA transcript can be reverse transcribed to produce cDNA in the cytosol that could theoretically reintegrate into the host genome. Early studies showed the nascent viral particles budding from the plasma membrane into the extracellular space, but these were shown to be morphologically immature (Bieda et al., 2001) . These particles are more likely to be non-infectious retroviral-like particles (RLPs), possibly lacking the full complement of genes and resulting from the transcription of HERV proviruses with intact gag genes, as the Gag protein is implicated in particle formation and budding (Akers et al., 2013) .
The expression of at least some HERVs is thought to be beneficial to the host. One mechanism by which this has occurred is through the domestication of a HERV gene for use by the organism (Patel et al., 2011) . A well-studied example of this is the case of the HERV-W and HERV-FRD env genes, which encode the proteins syncytin-1 and syncytin-2, respectively (Dupressoir et al., 2012) . These proteins are required for placenta formation, allowing fusion of cells to form the syncytiotrophoblast and contributing to immune tolerance of the fetus (Dupressoir et al., 2012) . In addition, genes and regulatory sequences from ERVs have been co-opted in the fight against viral infections, providing endogenous viral-element-derived immunity (Aswad & Katzourakis, 2012) . For example, in mice, an ERV LTR-derived regulatory element in APOBEC3 allows the upregulation of expression of this intrinsic restriction factor (Sanville et al., 2010) . Also in mice, the capsid-binding restriction factor Fv1 was found to be derived from the gag gene of an ERV (Best et al., 1996) . Fv1 protects against infection by a number of exogenous retroviruses by interacting with the capsid and blocking viral DNA entry into the nucleus (Yap et al., 2014) . Thus, these restriction factors provide endogenous viral-element-derived immunity by protecting the cell from exogenous retrovirus infection. Recently, HERV-H was found to be expressed as a long non-coding RNA (Lu et al., 2014) , a type of regulatory RNA molecule that associates with other factors linked to the stem cell phenotype, such as Octamer-4 (OCT4) and Mediator subunits, and is expressed in embryonic stem cells (Lu et al., 2014) .
Despite the potential for co-option of HERVs or other beneficial effects, there is a long association of HERVs with diseases such as autoimmune diseases and cancer. One way the cells could deal with potential detrimental effects is by restricting the activity of endogenous retroviruses. The expression of HERVs in adult tissues can be silenced by epigenetic mechanisms (Lavie et al., 2005) , although the CpG methylation of HERVs is variable and is possibly due to the spread of methylation from neighbouring gene loci (Reiss et al., 2007) . In addition, a number of intrinsic antiviral factors have been described that block virus replication by directly binding to and acting upon viral nucleic acids or proteins. The intrinsic restriction factor APOBEC3G is a cytosine deaminase that inhibits the retrotransposition of endogenous retroviruses (Esnault et al., 2005 (Esnault et al., , 2006 . It is hypothesized that APOBEC3G is most active in germ cells and during early embryogenesis, when HERVs are also thought to be active due to hypomethylation (Esnault et al., 2005) . Furthermore, there is evidence of past activity by a cytosine deaminase, resulting in the hypermutation of HERVs (Lee et al., 2008) . Other restriction factors include the TRIM family members, such as TRIM5a, which can restrict the expression of certain primate ERVs not found in humans (Kaiser et al., 2007) , and exogenous retroviruses such as human immunodeficiency virus type 1 (HIV-1) (Pertel et al., 2011) . Thus, there are cellular mechanisms that could repress HERV expression or cause deleterious mutations within the proviruses.
Furthermore, given that HERVs are part of the genome, they should theoretically be recognized as 'self', and immune tolerance of such self-antigens should be established during development (Tugnet et al., 2013) . Tolerance is not perfect and loss of self-tolerance is characteristic of autoimmune diseases. One mechanism by which HERVs could trigger an immune response is by producing nucleic acids or proteins that resemble the pathogen-associated molecular patterns (PAMPs) of exogenous viruses. Molecules generated by host tissues that are stressed or damaged are referred to as danger-associated molecular patterns (DAMPs) and activate the same classes of pattern recognition receptors (PRRs) as PAMPs (Tang et al., 2012) . In the case of HERVs, increased expression of RNA with retroviral-like structures or the presence of free cDNA in an unfamiliar compartment (i.e. the cytosol) could result in the activation of PRRs. The upregulation of HERV expression has been described in diseases such as cancer (Wang-Johanning et al., 2014) and autoimmunity (Saresella et al., 2009 ), but it is unclear whether HERV expression contributes to the disease phenotype or is a bystander effect. Should HERV molecules act as DAMPs, the activation of PRRs could thereby provide a mechanism by which HERVs contribute to pathogenesis.
Innate immune pathways activated by retroviruses
PRRs comprise an array of membrane-bound and cytosolic receptors that detect PAMPs and DAMPs (Tang et al., 2012) . The activation of PRRs invokes complex signalling pathways that ultimately alter gene expression. In particular, these pathways lead to the production of pro-inflammatory cytokines, chemokines and type I IFNs (IFN-a and IFN-b). These are the effector molecules that initiate an antiviral state and activate adaptive immune cells. There are a number of recent reviews on PRRs and signalling therefrom (Gürtler & Bowie, 2013; Lester & Li, 2014; O'Neill et al., 2013) ; here, we provide an overview of the pathways that could be relevant to the detection of HERVs.
Toll-like receptors (TLRs)
One class of PRR for the detection of viruses is the TLRs, transmembrane proteins found on either the plasma or the endosomal membrane. There are 10 human TLRs (TLR1-TLR10), each with a distinct subcellular localization and ligand specificity (Lester & Li, 2014) . TLRs have an extracellular ligand-binding domain comprising leucinerich repeats and a conserved cytosolic domain, the Toll-IL-1 resistance (TIR) domain; the TIR domain is also found in the IL-1 receptor superfamily and is essential for signalling from both the TLRs and IL-1R1 (O'Neill et al., 2013) . Signalling from the TLRs requires receptor dimerization and the recruitment of TIR domain-containing adaptor molecules, including myeloid differentiation factor 88 (MyD88), to the TIR domain of the receptor (Lester & Li, 2014) . This is followed by activation of a cascade of intracellular kinases and ubiquitin ligases, resulting in the nuclear translocation of transcription factors including (NF-kB) and IFN regulatory factors (IRFs) 3 and 7 (O'Neill et al., 2013) . The transcription factors bind to response elements in genes, resulting in the expression of proinflammatory cytokines and type I IFNs (Fig. 1) .
The plasma membrane-localized TLR4 was first described as the sensor for the bacterial product lipopolysaccharide (LPS) when it is bound to the protein myeloid differentiation factor 2 (MD2) (O'Neill et al., 2013) . Importantly, TLR4 can also detect viral glycoproteins, such as the Ebola virus glycoprotein and the envelope proteins of retroviruses including HIV-1 (Nazli et al., 2013; Okumura et al., 2010) . TLR3, -7, -8 and -9 sense microbial nucleic acids in the endosomal lumen: TLR3 detects dsRNA, both TLR7 and -8 sense ssRNA, and TLR9 recognizes unmethylated CpG DNA (Gürtler & Bowie, 2013) . More recently, TLR9 has been shown to recognize RNA : DNA hybrids (Rigby et al., 2014) . Given that the ligand-binding domain of these nucleic acid-sensing TLRs (NA-TLRs) is in the endosomal lumen, cytosolic PAMPs are unlikely to be sensed and this pathway is thought to be more important for the detection of exogenous viruses. However, the process of autophagy allows sampling of the cytosol and fusion of the autophagosome with the endosome (Tang et al., 2012) , possibly permitting the detection of cytosolic PAMPs by the endosomal TLRs.
Cytosolic PRRs
In addition to the TLRs, a number of PRRs have been described that reside in the cytosol or migrate to the cytosol following the detection of microbial nucleic acids (Fig. 2) . The retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) are a class of RNA helicases that recognize viral RNA in the cytoplasm and induce type I IFNs (Gürtler & Bowie, 2013) . The RLRs include RIG-I and melanoma differentiation-associated gene 5 (MDA5), both of which have two N-terminal caspase recruitment domains (CARDs) that are essential for signalling (Gürtler & Bowie, 2013) . RIG-I detects short dsRNA and ssRNA with a 59-triphosphate moiety, whereas MDA5 senses long dsRNA molecules (Kato et al., 2008) . A third RLR that lacks a CARD, laboratory of physiology and genetics 2 (LGP2), enhances the detection of RNA by MDA5 but not RIG-I (Childs et al., 2013) . Following detection of RNA ligands, RIG-I and MDA5 signal via homotypic CARD interactions with the mitochondrial outer-membrane-localized adaptor molecule mitochondrial antiviral signalling (MAVS), leading to the phosphorylation and activation of the transcription factors IRF3 and -7 (Loo & Gale, 2011) . The phosphorylated IRFs can translocate to the nucleus, bind to the IFN-stimulated regulatory element and induce IFN expression (Hiscott, 2007) .
Several cytosolic receptors for DNA have also been described, including the DNA-dependent activator of IFN regulatory factors (DAI), which detects long, dsDNA (Takaoka et al., 2007) . In addition, the absent in melanoma 2 (AIM2)-like receptors include the proteins AIM2, which senses dsDNA (Hornung et al., 2009) , and IFN-c-inducible protein 16 (IFI16), which detects ssDNA (Unterholzner et al., 2010) . Following detection of DNA in the cytosol, IFI16 recruits the adaptor stimulator of IFN genes (STING), leading to IFN-b production (Unterholzner et al., 2010) . Initially, this receptor was discovered using DNA from vaccinia virus (Unterholzner et al., 2010) , but it has since been found to detect DNA produced during lentivirus replication (Jakobsen et al., 2013) . The study showed that ssDNA with a stable stem region and dsDNA induced IFN-b production in an IFI16-dependent manner (Jakobsen et al., 2013) . Other cytosolic DNA sensors have been described, including DEAD box helicase 41 (DDX41) and cyclic GMP-AMP synthase (cGAS), the latter of which detects DNA from retroviruses and signals via STING and IRF3 for IFN induction (Gao et al., 2013) . More recently, cGAS has been shown to play a pivotal role in the antiviral response to both DNA and RNA viruses via the induction of IFN and IFN-stimulated gene (ISG) expression (Schoggins et al., 2014) . There are thus a number of cytosolic sensors that detect viral nucleic acids and initiate innate immune signalling. Whilst much of this work has been done with exogenous viruses, there is evidence that the same cellular mechanisms could also detect HERV expression.
Sensing of HERVs by innate immune receptors
Recently, a number of candidate receptors have been proposed that could sense retroviral DNA in the cytoplasm and RNA in the endosome. However, much of this work has been done with exogenous retroviruses, such as HIV-1, or murine ERVs (MuERVs), not with HERVs. Whilst the nucleic acids and proteins produced by HERV expression could generate endogenous ligands for the innate immune response (Fig. 3) , there is limited evidence to date for a direct interaction.
TLRs and HERVs
Only a few studies have investigated the role of TLRs in detecting HERVs. One member of the HERV-W family that is potentially associated with multiple sclerosis has been shown to interact with TLRs and to produce a proinflammatory response (Rolland et al., 2005 (Rolland et al., , 2006 . In this case, the surface subunit of the Env protein (ENV-SU) interacts with TLR4 and CD14 to stimulate the production of pro-inflammatory cytokines including IL-1b, IL-6 and TNF-a (Rolland et al., 2006) . Furthermore, this subunit can activate dendritic cells and induce a Th1 response (Rolland et al., 2006) , which is the activation of a subtype of helper T-cells that contribute to phagocyte-dependent inflammation and cell-mediated immunity (Murphy & Reiner, 2002 HERV-K dUTPase were found to be significantly associated with psoriasis (Ariza & Williams, 2011) . The recombinant WT and mutant dUTPase were able to induce NF-kB in a TLR2-dependent manner, resulting in a T-helper 1 (Th1) and Th17 cytokine response (Ariza & Williams, 2011) . Whilst TLR2 is thought normally to respond to bacterial lipopeptides, other protein ligands including the measles virus haemagglutinin protein are sensed by TLR2 (Kawai & Akira, 2009) . It is thus possible that other proteins including the HERV-K dUTPase could be detected by TLR2, although whether this reaction occurs in vivo remains to be demonstrated, particularly as it is thought to be intracellular whereas TLR2 is expressed on the cell surface. These two studies indicate that TLRs can respond to HERV proteins to induce a pro-inflammatory response.
There are a few reports of a role for the NA-TLRs in detecting MuERVs. First, the MuERV envelope glycoprotein, gp70, is considered to be an antigen against which a TLR7-dependent autoimmune response is directed in lupus-prone mice (Yoshinobu et al., 2009) . The expression of gp70 is increased following activation of TLR7 and -9 in a mouse model of lupus (Baudino et al., 2010) , providing a direct link between TLR activation and the upregulation of MuERV expression. Interestingly, the TLR-mediated expression of gp70 was distinct from the mechanism controlling basal levels of gp70 expression (Baudino et al., 2010) . Thus, there is a mechanism by which inflammation could lead to elevated serum gp70 levels, consistent with gp70 acting as an acute-phase protein in mice (Baudino et al., 2010) . TLR7 and -9 have a role in the pathogenesis of murine lupus, both by inducing an adaptive immune response to autoantigens and by increasing the expression of at least one class of autoantigen, the MuERV gp70 (Baudino et al., 2010) .
Another study showed an important role for NA-TLRs in the control of MuERV viraemia and the development of ERV-induced tumours (Yu et al., 2012) . Mice deficient in NA-TLR or the requisite signalling molecules showed enhanced MuERV mRNA expression and viral particle formation (Yu et al., 2012) . The absence of TLR7, alone or in combination with deficiencies in the other TLRs, resulted in an increase in MuERV gag mRNA levels and gp70 Env protein expression (Yu et al., 2012) . Likewise, deficiency in IFN regulatory factor 5 (IRF5), a specific signalling molecule used by TLR7 and -9, leads to increased gp70 env or gag mRNA levels, suggesting that TLR7 restricts MuERV expression via an IRF5-dependent pathway (Yu et al., 2012) . Only TLR7 had a non-redundant role in this immune surveillance. The role of the NA-TLRs was examined further in the context of MuERV-induced tumours. Acute T-cell lymphoblastic leukaemia developed only in the NA-TLR-deficient mice, suggesting that the combined effect of these TLRs is to provide a protective response against ERV-induced tumours (Yu et al., 2012) .
A general role for TLRs in the antibody response to exogenous retroviruses has been described recently. TLR7 was found to be involved in the germinal centre reaction, which facilitates antibody production and class switching, specifically in the acute response to murine exogenous retroviruses (Browne, 2011 (Browne, , 2013 . Furthermore, TLR7 was critical for the production of autoantibodies to gp70 (Yoshinobu et al., 2009) , and mice lacking TLR7 were unable to produce antibodies to MuERVs (Yu et al., 2012) . It was proposed that MuERVs are activated sporadically and that this allows for a protective, TLR7-dependent antibody response to control MuERV viraemia (Yu et al., 2012) . Whether a similar system functions in the surveillance of HERVs in humans is not yet known. The activation of NA-TLRs in response to HERV expression could potentially contribute to the development of antibodies to HERVs, which has been observed in a number of studies of human cancers (Wang-Johanning et al., 2008) and infection with HIV-1 (Michaud et al., 2014) . The NA-TLRs also promote autoimmune responses as they are fundamental to the activation of autoreactive B-cells (Koh et al., 2013) , which could include ERV antigens as well as other types of autoantigen (Baudino et al., 2010) . Thus, the NA-TLR-mediated control of ERVs could provide a link with the development of self antibodies in autoimmune diseases.
Detection of HERVs by cytosolic PRRs
As a large part of retrovirus replication takes place in the cytoplasm, the presence of cytosolic PRRs could allow early detection of the products of HERV expression. To date, no studies have identified a role for cytosolic RNA receptors in sensing HERV RNAs. There is evidence that HIV RNA can induce a RIG-I-dependent response (Berg et al., 2012 ), so it is theoretically possible that other retroviral RNAs, including HERVs, could also be detected by this PRR. Importantly, enzymes have been described that maintain nucleic acid homeostasis in the cytosol, mainly by degrading excess nucleic acids to prevent immune activation. A recent study has identified a mechanism that would restrict cytosolic RNA and could thus prevent the accumulation of HERV RNAs. the SKIV2L helicase degrades endogenous RNA molecules that would otherwise be immunostimulatory, thereby acting as a negative regulator of the RLRs (Eckard et al., 2014) . The SKIV2L gene is associated with susceptibility to systemic lupus erythematosus (Eckard et al., 2014) , providing further support for the theory that cytosolic nucleic acids can be The ssRNA and the RNA : DNA hybrid intermediate generated during reverse transcription would be sensed by TLR7 and TLR9, respectively, if they reached the endosome. There is no evidence yet that the ssRNA is sensed by cytosolic RNA PRRs. (c) The ssDNA produced following reverse transcription could be used to generate a dsDNA molecule for reintegration into the genome. (d) Alternatively, the cDNA could be degraded by the enzyme TREX1 or else detected by cytosolic PRRs such as IFI16 or cGAS, leading to type I IFN induction. (e) The RNA transcripts could also be read as mRNA for the production of viral proteins, possibly leading to particle formation. There is some evidence that even if only the Gag protein is synthesized, RLPs can be produced, although these may not package the viral genome. (f) The viral particles or RLPs could bud from the plasma membrane. TLR4 has been shown to sense the Env protein of at least one HERV, so it is feasible that the particles could activate a TLR4-mediated innate immune response.
linked to aberrant immune activation in autoimmune diseases. Whether HERV RNAs are also degraded by SKIV2L remains to be demonstrated.
TREX1 and cytosolic DNA accumulation
There is some evidence that HERV DNA could be detected by cytosolic PRRs and that the production of HERV DNA is restricted by the 39 repair exonuclease 1 (TREX1), a 39A59 exonuclease that degrades endogenous DNA (Paludan & Bowie, 2013) . TREX1 is found at the endoplasmic reticulum as part of the SET (suppressor of variegation, enhancer of zeste and trithorax) DNA repair complex (Yan et al., 2009) and is thought to have a critical role in restricting the amount of endogenous DNA in the cytosol (Stetson et al., 2008) . Activation of TLRs in conventional dendritic cells results in the upregulation of TREX1 expression via type I IFN and NF-kB (Xu et al., 2014) . Thus, TREX1 is induced by pro-inflammatory conditions and is thought to play a role in the innate immune response to DNA PAMPs and DAMPs.
The critical role for TREX1 in degrading DNA in the cytosol was discovered in TREX1 knockout mice, which develop a type I IFN response and multi-organ inflammation (Gall et al., 2012) . In TREX1-deficient cells, short ssDNA sequences were found to accumulate at the endoplasmic reticulum (Yang et al., 2007) . These ssDNA sequences were thought to be produced during replication, probably as a by-product of recombination and the repair of double-stranded breaks (Yang et al., 2007) . A subsequent study identified retroelements, including MuERVs, among the cytosolic DNA that accumulates in TREX1 deficiency (Stetson et al., 2008) . Based on this study, endogenous retroviral DNA is a substrate for TREX1 and can accumulate in TREX1-deficient cells. However, further work is required to confirm these findings and to identify the types of endogenous DNA molecules that are present in TREX1 knockout cells.
Whilst the TREX1 knockout mice displayed an IRF3-dependent immune response to the cytosolic DNA (Stetson et al., 2008) , the PRR that detects the DNA and induces this response was not identified in this study. More recent work has implicated one or more of the cytosolic receptors in the detection of DNA in TREX1-deficient cells. A critical role was identified for the adaptor molecule STING, in the development of type I IFN-dependent inflammation and autoimmunity (Gall et al., 2012) . This adaptor is used by a number of cytosolic DNA PRRs, including IFI16 and cGAS. IFI16 has been found to recognize retroviral DNA: either retrovirus-derived ssDNA with a stable stem region or dsDNA induced IFN-b production in an IFI16-dependent manner (Jakobsen et al., 2013) . The same study found similar responses to lentiviral ssDNA and dsDNA with cGAS and DDX41, and the knockdown of these PRRs also impaired IFN production in response to these DNA ligands (Jakobsen et al., 2013) . This suggests that there could be overlapping or redundant functions of these sensors. Importantly, a recent study showed that TREX1-deficient cells in which cGAS was also knocked out were unable to induce ISG expression in response to cytosolic DNA (Ablasser et al., 2014) . This is strong evidence of a primary role for cGAS in the detection of immunostimulatory DNA in the cytosol. The source of the ssDNA could be HERV cDNA; cGAS can induce IFN expression in response to retroviral cDNA from exogenous retroviruses including HIV-1 (Gao et al., 2013) . Thus, it is possible that endogenous retroviral DNA could serve as a ligand for cGAS, but this remains to be demonstrated directly.
It has been proposed that the level of HERV cDNA in the cytosol is kept below a threshold level by the action of TREX1 (Volkman & Stetson, 2014) ; in the case of TREX1 deficiency, the normally immunologically silent cDNA accumulates such that it becomes a DAMP that could activate the innate immune response. At least one human autoimmune disease, Aicardi-Goutières syndrome (AGS), can be caused by mutations in the TREX1 gene that lead to disruption of the normal DNA damage response and the accumulation of DNA in the cytosol (Yang et al., 2007) . Indeed, the lack of TREX1 in patients with AGS is thought to lead to an accumulation of HERV DNA in the cytoplasm, ultimately inducing a type I IFN response (Stetson et al., 2008) . Thus, TREX1 deficiency could cause chronic activation of DNA-sensing PRRs, accounting for the inflammatory disease and elevated type I IFN observed in these patients (Yang et al., 2007) . Interestingly, the use of reverse transcriptase inhibitors in TREX1 knockout mice resulted in improved survival and reduced markers of inflammation in autoimmune myocarditis (Beck-Engeser et al., 2011) . Thus, it is likely that there is a role for ERV nucleic acids in triggering the autoimmune response in TREX1 knockout mice and in humans with AGS. TREX1 is one of six genes the mutation of which is associated with AGS; other genes include components of the endonuclease complex that target RNA : DNA hybrids (RNASEH2A, -B and -C), the adenosine deaminases acting on RNA (ADAR), the SAM domain-and HD domain-containing protein 1 and the cytosolic dsRNA receptor MDA5 (Rice et al., 2013 . Along with TREX1, most of these genes encode enzymes that function in degrading or editing nucleic acids, minimizing the production of immunostimulatory nucleic acids including those produced following HERV expression. For example, SAMHD1 is a dNTPase that has been shown to restrict HIV-1 reverse transcription by depleting the pool of available dNTPs (St Gelais et al., 2012; Sze et al., 2013) . A more recent paper suggests that SAMHD1 could specifically degrade ssRNA molecules, including HIV-1 transcripts (Ryoo et al., 2014) , although this finding remains to be confirmed by other studies. It is possible that this enzyme could limit the production of HERV transcripts, which might otherwise accumulate in cells. Much of the work on AGS has been done using gene-knockout mice. Further work to study this in primary human cells would be of interest, particularly for the purposes of identifying which HERVs, if any, are the source of immunostimulatory nucleic acids.
Consequences of innate immune activation by HERVs
One of the consequences of activation of the innate immune response is the production of inflammatory mediators, including type I IFNs, cytokines and chemokines. Ordinarily, the immune response is curtailed once the threat (e.g. virus infection) has been eliminated; if it is not resolved, chronic inflammatory diseases can arise (Turner et al., 2014) . Thus, activation of the innate immune response by HERVs could be an initiating event that could lead to chronic inflammation, and this is one way in which HERVs could contribute to autoinflammatory and autoimmune diseases. The chronic induction of type I IFNs in particular could have a pathological effect, given the potent biological activity of these molecules. For example, type I IFNs released from one cell could bind to the IFN receptor (IFNAR1/2) on the same and neighbouring cells, inducing signalling cascades leading to the induction of ISG expression. This could put the cells into an antiviral state, in which many cellular metabolic processes are shut down and which can ultimately lead to apoptosis (Zuniga et al., 2007) . Apoptotic cells are normally cleared by phagocytes to prevent an immune reaction to cellular contents; improper clearance of apoptotic cells and chronic disease states are two factors contributing to the onset of autoimmunity (Szondy et al., 2014) . Furthermore, type I IFNs have immunomodulatory roles that include activating natural killer cells and stimulating the clonal expansion of cytotoxic T-cells (Zuniga et al., 2007) , thereby linking an initial innate immune response to the HERVs to a cellular immune response. In addition, the detection of HERVs by PRRs could ultimately potentiate the production of autoantibodies. This has been shown for self nucleic acids that activate TLRs and promote the production of autoantibodies in systemic lupus erythematosus (Barrat et al., 2005) . Whether these self nucleic acids comprise or even include HERVs remains to be demonstrated, although work with MuERVs (Yoshinobu et al., 2009) suggests it is possible.
Importantly, there is potential for the development of a positive-feedback loop by which the inflammation induced by HERVs could lead to increased HERV expression. Cellular transcription factors can bind to the LTRs of HERVs in order to regulate expression of the provirus. This is important given the alteration in transcription factor expression and activation in different disease states. A recent in silico study identified numerous transcription factor binding sites within the HERV-K 59 LTR, including those for the pro-inflammatory transcription factor NF-kB and the IFN-stimulated regulatory element (Manghera & Douville, 2013) . NF-kB is an important transcription factor in the inflammatory response; it is activated following signalling from the TLRs and it induces the expression of pro-inflammatory cytokines and type I IFNs. The presence of NF-kB-binding sites in HERV LTRs could thus result in increased expression during inflammation. Experimentally, the treatment of cells with LPS, the ligand for TLR4, or TNF-a increased the expression of HERV-K, HERV-H and HERV-W RNA (Johnston et al., 2001) . Both TLR4 and TNF-a receptor signalling can induce NF-kB, which could then bind to the response elements found in the HERV LTRs. This was demonstrated for HERV-W, wherein TNFa signalling resulted in NF-kB binding to the promoter and the induction of HERV-W (specifically, the Env protein syncytin-1) expression (Mameli et al., 2007) . This could lead to chronic activation of the innate immune response.
Alternatively, the expression of certain HERVs could result in immune suppression. This has been demonstrated for a couple of HERV Env proteins, HERV-FRD and HERV-H. The HERV-FRD Env protein (syncytin-2) is immunosuppressive, preventing a maternal immune response to the alloantigens of the fetus (Mangeney et al., 2007) . In addition, the HERV-H Env protein was also found to be immunosuppressive, preventing immune rejection of tumour cells implanted in mice (Mangeney et al., 2001) . The transmembrane domain of the Env protein of HIV-1 and of some endogenous retroviruses has an immunosuppressive domain (isu) that modulates cytokine production by PBMCs (Denner, 2014) . Further to this, the HERV-K Env protein has been found to induce the production of IL-10 ( Morozov et al., 2013) , which is an immunosuppressive cytokine. However, compared with other retroviruses, the HERV-K isu was relatively variable (Denner, 2014) , and therefore it might not be as potent at immunosuppression. It has been proposed that immunosuppression by HERVs could contribute to immune evasion by cancer cells, permitting tumour growth (Kassiotis, 2014) . Thus, the consequences of HERV expression could include promotion of tumorigenesis by immune suppression.
Epilogue
The products of HERV expression have the potential to interact with components of the innate immune response and to activate pro-inflammatory signalling pathways. There is direct evidence of an interaction between certain HERV proteins and TLRs, as well as indirect evidence that HERV nucleic acids could activate cytosolic PRRs. With respect to the latter, further studies into which PRRs are involved and which structures of HERV nucleic acids form the ligands for the PRRs would help to define the mechanism of HERV-induced immune activation. This activation could contribute to the inflammation observed in autoimmune and autoinflammatory diseases, as well as increasing HERV expression further by the binding of proinflammatory transcription factors (such as NF-kB) to the HERV LTRs. In addition, HERV expression could increase autoantibody formation via TLR activation. Alternatively, there is evidence that certain HERV Env proteins could be immunosuppressive, potentially impairing the immune response to exogenous pathogens and tumours. Many questions remain about the expression of HERVs in cells and whether they contribute to pathogenesis. An interaction with the immune response is one way in which HERVs could have pathogenic potential.
